A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis

NCT05096364 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
251
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akeso